Fingerprint
Dive into the research topics of 'Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression
Devora Champa, Marika A. Russo, Xiao Hui Liao, Samuel Refetoff, Ronald A. Ghossein, Antonio Di Cristofano
Research output: Contribution to journal › Article › peer-review
28
Scopus
citations